Facilitated By

San Antonio Medical Foundation

THE HIPPO SIGNALING PATHWAY IN PANCREATIC EPITHELIAL CELLS ORCHESTRATE THE INFLAMMATORY RESPONSE

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Wang, Pei
Funded by
NIH-DIABETES/DIGESTIVE/KIDNEY DISEASES
Research Start Date
Status
Active

The inflammatory disorders of the pancreas have two forms, acute and chronic. Acute pancreatitiscauses severe illness and reduces life expectancy. However, besides supportive care, there is no effectivetreatment for the disease due to a lack of understanding of the early cellular events important in thepathophysiology of this disease. Not only is chronic pancreatitis as bad in that it does not heal or improve andonly gets worse over time leading to permanent damage of the pancreas, it is also the top risk factor forpancreatic adenocarcinoma (PDAC). Similar to the acute form, there is no effective treatment for this disease.This tissue damage causes a rapid sterile inflammatory response (SIR) characterized by edema, immune cellinfiltration, and further acinar cell death. A lot of evidence points towards the SIR having a vital role inpancreatic damage, but the crucial link between acinar cell injury and initiation of the SIR has not been wellunderstood. The Hippo signaling pathway is best known for its ability in controlling organ size, cell proliferationand regeneration. Noticeably, this pathway responds to various upstream stimuli such as mechanical signals,cellular stress, extracellular stimuli and adhesion cues, making it a good candidate as a microenvironmentsensor for epithelial cells to orchestrate the inflammatory response during tissue injury and repair.Nevertheless, the role of the Hippo pathway in directly regulating inflammatory reactions has not beeninvestigated. Our preliminary data showed that inactivation of the Hippo pathway by knocking out Lats1&2,specifically in acinar cells, rapidly induced the inflammatory response in the pancreas. Notably, ourunpublished data indicated that this inflammatory response was not the secondary effect caused by the deathof Lats1&2 deficient acinar cells, suggesting the novel function of the Hippo pathway to directly regulateepithelial-immune cell interactions. We hypothesize that YAP/TAZ mediated transcription in Hippo pathway-inactivated pancreatic acinar cells plays important roles in recruiting and educating immune cells to orchestratethe inflammatory response. Our hypothesis will be tested with three specific aims. First, we will test thehypothesis that expression of YAP1 or TAZ are necessary for induction of pro-inflammatory genes in Lats1&2null pancreatic acinar cells using a genetic approach. Second, we will investigate how YAP and TAZ induceinflammation through transcriptional regulation. Third, we will test the hypothesis that Yap and/or Taz arenecessary for the inflammation and fibrosis associated with acute or chronic pancreatitis. Our proposal will notonly investigate the novel functions of Hippo pathways, but will also address the fundamental mechanisms bywhich epithelial cells specify the communication with immune cells during inflammation. Our research will haveimportant implications to improve understanding of the pathophysiology of inflammatory diseases in thepancreas and for potential therapeutic development.

Collaborative Project
Basic Research
Cancer